SARAH DEAN: Open Payments
NPI 1083002307 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 38 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $166 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $199 |
| Madrigal Pharmaceuticals | 6 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $128 |
| Janssen Biotech, Inc. | 5 | $107 |
| Ardelyx, Inc. | 3 | $78 |
| Phathom Pharmaceuticals, Inc. | 4 | $59 |
| Novo Nordisk Inc | 2 | $59 |
| GENZYME CORPORATION | 1 | $28 |
| Intercept Pharmaceuticals, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: REZDIFFRA, TREMFYA, ENTYVIO, LILETTA, IBSRELA, RINVOQ, VOQUEZNA, Wegovy.
Industry payments across CT — which companies pay providers there.
